Nutritional Intervention for Patients With Multiple Cancer Types

Launched by FIRST HOSPITAL OF CHINA MEDICAL UNIVERSITY · Sep 22, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how nutritional support can help patients with various types of cancer during their treatment, especially around the time of surgery. The goal is to see if improving a patient's nutrition can lead to better health outcomes, including longer periods without the cancer progressing and improved quality of life. They are currently recruiting participants aged 18 to 80 who have specific types of cancer, such as lung or colorectal cancer, and who are planning to have surgery.

To join the study, participants need to be able to communicate and understand instructions, have a certain level of nutritional risk, and expect to live for at least six months. Those with certain health issues or who are pregnant or breastfeeding cannot participate. If eligible, participants can expect regular nutritional support and follow-ups to monitor their progress throughout the trial. This study aims to gather important information that could help improve care for cancer patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • ① Age ≥18 years old, \<80 years old, male or female; ② The patient signed the informed consent and volunteered to participate in the study; ③ Patients with malignant tumors (laryngeal cancer, esophageal cancer, lung cancer, gastric cancer, colorectal cancer, liver cancer, pancreatic cancer) evaluated by clinical stage II to IV; ④ Patients undergoing tumor surgery; ⑤ Patients with NRS 2002 score ≥ 3 after management risk screening; ⑥ Basic reading and communication skills; ⑦ Have the ability to act; Patients with a life expectancy greater than 6 months;
• Exclusion Criteria:
• • ① Acute onset of chronic disease; ② Pregnant or lactating women; ③ Patients with contraindications and no tumor surgery; (4) Patients with malignant tumors (laryngeal cancer, esophageal cancer, lung cancer, stomach cancer, colorectal cancer, liver cancer, pancreatic cancer) were confirmed by pathology and/or cytology after surgery; ⑤ Combined with cognitive dysfunction, mental disorder, consciousness disorder or unwillingness to cooperate; ⑥ Patients with severe gastrointestinal symptoms, liver and renal insufficiency (alanine aminotransferase ALT≥2 times the upper limit of normal value; Total bilirubin Tbil≥2 times the upper limit of normal value; Creatinine Cr≥2 times the upper limit of normal value); (7) Patients with two or more types of tumors; Long-term bed rest, hemiplegia or coma; ⑨ Severe dysfunction of liver, kidney and other organs; ⑩ Allergy or intolerance to nutrients or their main components (such as lactose or galactose, etc.).